Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Second Canadian Conference on Multiple Sclerosis.

B G Weinshenker1, R Nelson

  • 1Division of Neurology, University of Ottawa, Ontario, Canada.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|February 1, 1990
PubMed
Summary

Multiple Sclerosis (MS) research explores genetic versus environmental causes and trial efficacy. Magnetic Resonance Imaging (MRI) shows promise in monitoring MS activity and correlating with disability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of MOG antibody associated disorders: results of an international survey.

Journal of neurology·2020
Same author

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Journal of neurology, neurosurgery, and psychiatry·2019
Same author

[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Der Nervenarzt·2018
Same author

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Journal of neuroinflammation·2018
Same author

A population-based prospective study of optic neuritis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2017
Same author

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.

Multiple sclerosis and related disorders·2015

Area of Science:

  • Neurology
  • Epidemiology
  • Clinical Trials

Background:

  • Multiple Sclerosis (MS) epidemiology and clinical trial interpretation were discussed.
  • The etiology of MS remains debated, with theories including genetic predisposition, environmental triggers, or multigenic factors.

Purpose of the Study:

  • To summarize current understanding of MS epidemiology.
  • To review the challenges and interpretation of clinical therapeutic trials for MS.
  • To explore the role of diagnostic tools in MS management.

Main Methods:

  • Symposium discussion synthesizing existing research and clinical observations.
  • Review of clinical trial outcomes for immunosuppressive agents in progressive MS.
  • Evaluation of Magnetic Resonance Imaging (MRI) for monitoring MS activity.

Related Experiment Videos

Main Results:

  • No immunosuppressive agents have proven effective for progressive MS management to date.
  • Magnetic Resonance Imaging (MRI) demonstrates high sensitivity for tracking MS activity.
  • Preliminary data indicate a correlation between MRI activity and clinical disability progression.

Conclusions:

  • The cause of MS (genetic vs. environmental) requires further investigation.
  • Current clinical trials have not established efficacy for progressive MS treatments.
  • MRI is a valuable tool for monitoring MS progression and potentially correlating with clinical outcomes.